Agreements With Quest Diagnostics Incorporated |
9 Months Ended |
---|---|
Sep. 30, 2020 | |
Agreements With Quest Diagnostics Incorporated [Abstract] | |
Agreements With Quest Diagnostics Incorporated | 2. AGREEMENTS WITH QUEST DIAGNOSTICS INCORPORATED In March 2015, the Company entered into a commercial agreement with Quest Diagnostics, Incorporated (“Quest Diagnostics”). Pursuant to this agreement, all OVA1 U.S. testing services for Quest Diagnostics customers were transferred to ASPIRA’s wholly-owned subsidiary, ASPiRA LABS, as of August 2015. Pursuant to this agreement, as amended as of April 10, 2015, March 11, 2017, March 1, 2018 and March 11, 2020, Quest Diagnostics has continued to provide blood draw and logistics support by transporting specimens from its clients to ASPiRA LABS for testing in exchange for a market value fee.
|